Kenneth Cummings to Tobacco Use
This is a "connection" page, showing publications Kenneth Cummings has written about Tobacco Use.
Connection Strength
3.125
-
Identifying factors that conjointly influence nicotine vaping product relative harm perception among smokers and recent ex-smokers: Findings from the 2016 ITC Four Country Smoking and Vaping Survey. Drug Alcohol Depend. 2021 01 01; 218:108370.
Score: 0.176
-
State Tobacco Excise Taxation, Comprehensive Smoke-free Air Laws, and Tobacco Control Appropriations as Predictors of Smoking Cessation Success in the United States. J Public Health Manag Pract. 2020 Sep/Oct; 26(5):E1-E4.
Score: 0.175
-
Prevalence, Use Behaviors, and Preferences among Users of Heated Tobacco Products: Findings from the 2018 ITC Japan Survey. Int J Environ Res Public Health. 2019 11 21; 16(23).
Score: 0.166
-
Predicting the future of smoking in a rapidly evolving nicotine market-place. Addiction. 2019 10; 114 Suppl 1:3-5.
Score: 0.164
-
Flavour types used by youth and adult tobacco users in wave 2 of the Population Assessment of Tobacco and Health (PATH) Study 2014-2015. Tob Control. 2020 07; 29(4):432-446.
Score: 0.164
-
Harm perceptions and tobacco use initiation among youth in Wave 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study. Prev Med. 2019 06; 123:185-191.
Score: 0.158
-
Correlates of Transitions in Tobacco Product Use by U.S. Adult Tobacco Users between 2013?2014 and 2014?2015: Findings from the PATH Study Wave 1 and Wave 2. Int J Environ Res Public Health. 2018 11 14; 15(11).
Score: 0.154
-
Transitions in Tobacco Product Use by U.S. Adults between 2013?2014 and 2014?2015: Findings from the PATH Study Wave 1 and Wave 2. Int J Environ Res Public Health. 2018 11 09; 15(11).
Score: 0.154
-
Mental Health Problems and Onset of Tobacco Use Among 12- to 24-Year-Olds in the PATH Study. J Am Acad Child Adolesc Psychiatry. 2018 12; 57(12):944-954.e4.
Score: 0.153
-
State Tobacco Policies as Predictors of Evidence-Based Cessation Method Usage: Results From a Large, Nationally Representative Dataset. Nicotine Tob Res. 2018 09 25; 20(11):1336-1343.
Score: 0.153
-
Longitudinal associations between youth tobacco and substance use in waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study. Drug Alcohol Depend. 2018 10 01; 191:25-36.
Score: 0.151
-
Adult interest in using a hypothetical modified risk tobacco product: findings from wave 1 of the Population Assessment of Tobacco and Health Study (2013-14). Addiction. 2018 Jan; 113(1):113-124.
Score: 0.142
-
Tobacco Use Prevalence and Outcomes Among Perinatal Patients Assessed Through an "Opt-out" Cessation and Follow-Up Clinical Program. Matern Child Health J. 2017 Sep; 21(9):1790-1797.
Score: 0.142
-
Indicators of dependence for different types of tobacco product users: Descriptive findings from Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health (PATH) study. Drug Alcohol Depend. 2017 09 01; 178:257-266.
Score: 0.140
-
Mexico SimSmoke: how changes in tobacco control policies would impact smoking prevalence and smoking attributable deaths in Mexico. Glob Public Health. 2017 07; 12(7):830-845.
Score: 0.127
-
How can patients who are not referred for treatment receive the best treatment available? Cancer. 2014 Jun 01; 120(11):1750-1.
Score: 0.113
-
Automated tobacco assessment and cessation support for cancer patients. Cancer. 2014 Feb 15; 120(4):562-9.
Score: 0.109
-
Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. J Oncol Pract. 2013 Sep; 9(5):258-62.
Score: 0.107
-
Predictors of E-cigarette and Cigarette Use Trajectory Classes from Early Adolescence to Emerging Adulthood Across Four Years (2013-2017) of the PATH Study. Nicotine Tob Res. 2023 02 09; 25(3):421-429.
Score: 0.052
-
Optimizing tobacco treatment delivery for people with HIV: trial protocol for a randomized controlled trial. Addict Sci Clin Pract. 2022 Nov 05; 17(1):61.
Score: 0.051
-
Tobacco Use and Respiratory Symptoms Among Adults: Findings From the Longitudinal Population Assessment of Tobacco and Health (PATH) Study 2014-2016. Nicotine Tob Res. 2022 10 17; 24(10):1607-1618.
Score: 0.051
-
Tobacco Product Use and Functionally Important Respiratory Symptoms Among US Adolescents/Young Adults. Acad Pediatr. 2022 Aug; 22(6):1006-1016.
Score: 0.049
-
Validation of the Wave 1 and Wave 2 Population Assessment of Tobacco and Health (PATH) Study Indicators of Tobacco Dependence Using Biomarkers of Nicotine Exposure Across Tobacco Products. Nicotine Tob Res. 2022 01 01; 24(1):10-19.
Score: 0.048
-
Validation of an Index for Functionally Important Respiratory Symptoms among Adults in the Nationally Representative Population Assessment of Tobacco and Health Study, 2014-2016. Int J Environ Res Public Health. 2021 09 14; 18(18).
Score: 0.047
-
The Illegal Experimental Tobacco Marketplace I: Effects of Vaping Product Bans. Nicotine Tob Res. 2021 08 29; 23(10):1744-1753.
Score: 0.047
-
Estimating the Impact of Tobacco Parity and Harm Reduction Tax Proposals Using the Experimental Tobacco Marketplace. Int J Environ Res Public Health. 2021 07 23; 18(15).
Score: 0.046
-
Predictive validity of the adult tobacco dependence index: Findings from waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) study. Drug Alcohol Depend. 2020 09 01; 214:108134.
Score: 0.043
-
Adult perceptions of the relative harm of tobacco products and subsequent tobacco product use: Longitudinal findings from waves 1 and 2 of the population assessment of tobacco and health (PATH) study. Addict Behav. 2020 07; 106:106337.
Score: 0.042